Recommendations on Surveillance for Differentiated Thyroid Carcinoma in Children with PTEN Hamartoma Tumor Syndrome

被引:27
作者
Jonker, L. A. [1 ]
Lebbink, C. A. [1 ,2 ]
Jongmans, M. C. J. [2 ,3 ]
Nievelstein, R. A. J. [2 ,4 ]
Merks, J. H. M. [2 ]
Nieveen van Dijkum, E. J. M. [5 ]
Links, T. P. [6 ]
Hoogerbrugge, N. [7 ]
van Trotsenburg, A. S. P. [8 ]
van Santen, H. M. [1 ,2 ]
机构
[1] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Endocrinol, POB 85090, NL-3508 AB Utrecht, Netherlands
[2] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Dept Genet, Utrecht, Netherlands
[4] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Radiol & Nucl Med, Utrecht, Netherlands
[5] Univ Amsterdam, Med Ctr, Dept Surg, Canc Ctr Amsterdam, Amsterdam, Netherlands
[6] Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands
[7] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, Nijmegen, Netherlands
[8] Univ Amsterdam, Emma Childrens Hosp, Dept Pediat Endocrinol, Med Ctr, Amsterdam, Netherlands
关键词
Differentiated thyroid carcinoma; PTEN hamartoma tumor syndrome; pediatric; Thyroid carcinoma surveillance program; Thyroid cancer genetics; COWDEN SYNDROME; GERMLINE PTEN; PHOSPHATIDYLINOSITOL; 3-KINASE/AKT; CANCER; RISK; INDIVIDUALS; ADOLESCENTS; DISEASE;
D O I
10.1159/000508872
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background:PTEN hamartoma tumor syndrome (PHTS) represents a group of syndromes caused by a mutation in thePTENgene. Children with a germlinePTENmutation have an increased risk of developing differentiated thyroid carcinoma (DTC). Several guidelines have focused on thyroid surveillance in these children, but studies substantiating these recommendations are lacking.Objective:The present study intends to provide the available evidence for a thyroid carcinoma surveillance program in children with PHTS.Methods:An extensive literature search was performed to identify all studies on DTC in pediatric PHTS patients. Two pediatric cases are presented to illustrate the pros and cons of thyroid carcinoma surveillance. Recommendations for other patient groups at risk for DTC were evaluated. Consensus within the study team on recommendations for children with PHTS was reached by balancing the incidence and behavior of DTC with the pros and cons of thyroid surveillance, and the different surveillance methods.Results:In 5 cohort studies the incidence of DTC in childhood ranged from 4 to 12%. In total 57 cases of DTC and/or benign nodular disease in pediatric PHTS patients were identified, of which 27 had proven DTC, with a median age of 12 years (range 4-17). Follicular thyroid carcinoma (FTC) was diagnosed in 52% of the pediatric DTC patients. No evidence was found for a different clinical behavior of DTC in PHTS patients compared to sporadic DTC.Conclusions:Children with PHTS are at increased risk for developing DTC, with 4 years being the youngest age reported at presentation and FTC being overrepresented. DTC in pediatric PHTS patients does not seem to be more aggressive than sporadic DTC.Recommendations:Surveillance for DTC in pediatric PHTS patients seems justified, as early diagnosis may decrease morbidity. Consensus within the study team was reached to recommend surveillance from the age of 10 years onwards, since at that age the incidence of DTC seems to reach 5%. Surveillance for DTC should consist of yearly neck palpation and triennial thyroid ultrasound. Surveillance in children with PHTS should be performed in a center of excellence for pediatric thyroid disease or PHTS.
引用
收藏
页码:234 / 242
页数:9
相关论文
共 33 条
[1]   THE ASSOCIATION BETWEEN LYMPH NODE METASTASIS AND MOLECULAR MARKERS IN DIFFERENTIATED THYROID CANCER [J].
Aydogan, B., I ;
Ersoz, C. C. ;
Sak, S. D. ;
Gullu, S. .
ACTA ENDOCRINOLOGICA-BUCHAREST, 2018, 14 (01) :55-65
[2]   Pediatric Cancer Predisposition and Surveillance: An Overview, and a Tribute to Alfred G. Knudson Jr [J].
Brodeur, Garrett M. ;
Nichols, Kim E. ;
Plon, Sharon E. ;
Schiffman, Joshua D. ;
Malkin, David .
CLINICAL CANCER RESEARCH, 2017, 23 (11) :E1-E5
[3]   High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome [J].
Bubien, Virginie ;
Bonnet, Francoise ;
Brouste, Veronique ;
Hoppe, Stephanie ;
Barouk-Simonet, Emmanuelle ;
David, Albert ;
Edery, Patrick ;
Bottani, Armand ;
Layet, Valerie ;
Caron, Olivier ;
Gilbert-Dussardier, Brigitte ;
Delnatte, Capucine ;
Dugast, Catherine ;
Fricker, Jean-Pierre ;
Bonneau, Dominique ;
Sevenet, Nicolas ;
Longy, Michel ;
Caux, Frederic .
JOURNAL OF MEDICAL GENETICS, 2013, 50 (04) :255-263
[4]   GDC-0941 Inhibits Metastatic Characteristics of Thyroid Carcinomas by Targeting both the Phosphoinositide-3 Kinase (PI3K) and Hypoxia-Inducible Factor-1α (HIF-1α) Pathways [J].
Burrows, Natalie ;
Babur, Muhammad ;
Resch, Julia ;
Ridsdale, Sophie ;
Mejin, Melissa ;
Rowling, Emily J. ;
Brabant, Georg ;
Williams, Kaye J. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (12) :E1934-E1943
[5]   Modeling Anaplastic Thyroid Carcinoma in the Mouse [J].
Champa, Devora ;
Di Cristofano, Antonio .
HORMONES & CANCER, 2015, 6 (01) :37-44
[6]   Balancing the benefits and harms of thyroid cancer surveillance in survivors of Childhood, adolescent and young adult cancer: Recommendations from the international Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium [J].
Clement, S. C. ;
Kremer, L. C. M. ;
Verburg, F. A. ;
Simmons, J. H. ;
Goldfarb, M. ;
Peeters, R. P. ;
Alexander, E. K. ;
Bardi, E. ;
Brignardello, E. ;
Constine, L. S. ;
Dinauer, C. A. ;
Drozd, V. M. ;
Felicetti, F. ;
Frey, E. ;
Heinzel, A. ;
van den Heuvel-Eibrink, M. M. ;
Huang, S. A. ;
Links, T. P. ;
Lorenz, K. ;
Mulder, R. L. ;
Neggers, S. J. ;
van Dijkum, E. J. M. Nieveen ;
Oeffinger, K. C. ;
van Rijn, R. R. ;
Rivkees, S. A. ;
Ronckers, C. M. ;
Schneider, A. B. ;
Skinner, R. ;
Wasserman, J. D. ;
Wynn, T. ;
Hudson, M. M. ;
Nathan, P. C. ;
van Santen, H. M. .
CANCER TREATMENT REVIEWS, 2018, 63 :28-39
[7]   Is outcome of differentiated thyroid carcinoma influenced by tumor stage at diagnosis? [J].
Clement, S. C. ;
Kremer, L. C. M. ;
Links, T. P. ;
Mulder, R. L. ;
Ronckers, C. M. ;
van Eck-Smit, B. L. F. ;
van Rijn, R. R. ;
van der Pal, H. J. H. ;
Tissing, W. J. E. ;
Janssens, G. O. ;
van den Heuvel-Eibrink, M. M. ;
Neggers, S. J. C. M. M. ;
van Dijkum, E. J. M. Nieveen ;
Peeters, R. P. ;
van Santen, H. M. .
CANCER TREATMENT REVIEWS, 2015, 41 (01) :9-16
[8]   NCCN Guidelines® Insights Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017 Featured Updates to the NCCN Guidelines [J].
Daly, Mary B. ;
Pilarski, Robert ;
Berry, Michael ;
Buys, Saundra S. ;
Farmer, Meagan ;
Friedman, Susan ;
Garber, Judy E. ;
Kauff, Noah D. ;
Khan, Seema ;
Klein, Catherine ;
Kohlmann, Wendy ;
Kurian, Allison ;
Litton, Jennifer K. ;
Madlensky, Lisa ;
Merajver, Sofia D. ;
Offit, Kenneth ;
Pal, Tuya ;
Reiser, Gwen ;
Shannon, Kristen Mahoney ;
Swisher, Elizabeth ;
Vinayak, Shaveta ;
Voian, Nicoleta C. ;
Weitzel, Jeffrey N. ;
Wick, Myra J. ;
Wiesner, Georgia L. ;
Dwyer, Mary ;
Darlow, Susan .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (01) :9-19
[9]   Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer [J].
Francis, Gary L. ;
Waguespack, Steven G. ;
Bauer, Andrew J. ;
Angelos, Peter ;
Benvenga, Salvatore ;
Cerutti, Janete M. ;
Dinauer, Catherine A. ;
Hamilton, Jill ;
Hay, Ian D. ;
Luster, Markus ;
Parisi, Marguerite T. ;
Rachmiel, Marianna ;
Thompson, Geoffrey B. ;
Yamashita, Shunichi .
THYROID, 2015, 25 (07) :716-759
[10]  
Group UC, 2017, GUID MAN TUM RISK PT